REDHILL BIOPHARMA LTD. Revenue
REDHILL BIOPHARMA LTD. (RDHL) reported Revenue of $4.08 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Income Statement › Other Income
ifrs-full:Revenue · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. revenue for the quarter ending 2022-06-30 was $18.35M, a 14.68% decline year-over-year.
- REDHILL BIOPHARMA LTD. revenue for the quarter ending 2021-06-30 was $21.50M, a 2.89% increase year-over-year.
- REDHILL BIOPHARMA LTD. revenue for the quarter ending 2020-06-30 was $20.90M, a 1237.11% increase year-over-year.
- REDHILL BIOPHARMA LTD. revenue for the quarter ending 2019-06-30 was $1.56M, a 33.49% decline year-over-year.
| Period end | Revenue 3 month | Revenue 6 month | Revenue 12 month |
|---|---|---|---|
| 2025-06-30 | $4.08M 6-K · filed 2025-09-05 | ||
| 2024-12-31 | $8.04M 20-F · filed 2025-04-10 | ||
| 2024-06-30 | $2.57M 6-K · filed 2025-09-05 | ||
| 2023-12-31 | $6.53M 20-F · filed 2025-04-10 | ||
| 2023-06-30 | $5.39M 6-K · filed 2024-08-29 | ||
| 2022-12-31 | $61.80M 20-F · filed 2025-04-10 | ||
| 2022-06-30 | $18.35M 6-K · filed 2022-11-07 | $31.45M 6-K · filed 2023-08-17 | |
| 2021-12-31 | $85.76M 20-F · filed 2024-04-08 | ||
| 2021-06-30 | $21.50M 6-K · filed 2022-11-07 | $42.08M 6-K · filed 2022-11-07 | |
| 2020-12-31 | $64.36M 20-F · filed 2023-04-28 | ||
| 2020-06-30 | $20.90M 6-K · filed 2021-08-26 | $21.95M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $6.29M 20-F · filed 2022-03-17 | ||
| 2019-06-30 | $1.56M 6-K · filed 2020-08-13 | $3.30M 6-K · filed 2020-08-13 | |
| 2018-12-31 | $8.36M 20-F · filed 2021-03-18 | ||
| 2018-06-30 | $2.35M 6-K · filed 2019-07-23 | $4.79M 6-K · filed 2019-07-23 | |
| 2017-12-31 | $4.01M 20-F · filed 2020-03-04 | ||
| 2017-06-30 | $483.00K 6-K · filed 2018-08-30 | $483.00K 6-K · filed 2018-08-30 | |
| 2016-12-31 | $101.00K 20-F · filed 2019-02-26 | ||
| 2015-12-31 | $3.00K 20-F · filed 2018-02-22 |